本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Pasithea Therapeutics Corp.

0.5110
+0.00430.85%
成交量:8,842
成交額:4,592.77
市值:1,707.48萬
市盈率:-0.34
高:0.5253
開:0.5250
低:0.5101
收:0.5067
52周最高:2.06
52周最低:0.2810
股本:3,341.44萬
流通股本:1,020.20萬
量比:0.32
換手率:0.09%
股息:- -
股息率:- -
每股收益(TTM):-1.4820
每股收益(LYR):-2.9100
淨資產收益率:-65.49%
總資產收益率:-36.00%
市淨率:0.34
市盈率(LYR):-0.18

資料載入中...

2023/03/30

員工持股計劃

S-8 - Securities to be offered to employees in employee benefit plans
2023/03/10

重要事件披露

8-K - Current report
2023/02/15

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/01/24

重要事件披露

8-K - Current report
2023/01/13

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/01/10

超過5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2022/12/14

重要事件披露

8-K - Current report
2022/12/14

超過5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2022/11/14

SEC問詢函

CORRESP [Cover] - Correspondence
2022/11/14

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]
2022/11/01

超過5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2022/10/20

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2022/10/12

重要事件披露

8-K - Current report
2022/09/21

員工持股計劃

S-8 - Securities to be offered to employees in employee benefit plans
2022/09/20

重要事件披露

8-K - Current report
2022/09/06

超過5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2022/09/01

超過5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2022/08/29

重要事件披露

8-K/A [Amend] - Current report
2022/08/15

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]
2022/08/11

超過5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership